NEW YORK (Reuters Health) - In postmenopausal women with low bone mineral density, long-term bisphosphonate therapy appears to benefit the periodontium, researchers report in a September 10 online ...
If Sally Field is to be believed, then she really, really likes Boniva, the bone loss drug that she currently shills for in TV commercials. And if Cheryl Ladd is considered a reliable source, then ...
The use of bisphosphonates seems to be associated with the development of ONJ. Length of exposure seems to be the most important risk factor for this complication. The type of bisphosphonate may play ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results